| 000 | 01049 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517193503.0 | ||
| 264 | 0 | _c20190827 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdx775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTutt, A | |
| 245 | 0 | 0 |
_aInhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c01 2018 |
||
| 300 |
_a18-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aBenzimidazoles |
| 650 | 0 | 4 | _aBreast Neoplasms |
| 650 | 0 | 4 | _aCarboplatin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aPaclitaxel |
| 650 | 0 | 4 | _aTemozolomide |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 1 _gp. 18-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdx775 _zAvailable from publisher's website |
| 999 |
_c27947644 _d27947644 |
||